Compare Novartis with A.V.COTTEX - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs A.V.COTTEX - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS A.V.COTTEX NOVARTIS/
A.V.COTTEX
 
P/E (TTM) x 81.8 41.3 197.9% View Chart
P/BV x 2.6 1.2 208.0% View Chart
Dividend Yield % 1.4 0.0 -  

Financials

 NOVARTIS   A.V.COTTEX
EQUITY SHARE DATA
    NOVARTIS
Mar-21
A.V.COTTEX
Mar-21
NOVARTIS/
A.V.COTTEX
5-Yr Chart
Click to enlarge
High Rs77010 7,897.4%   
Low Rs5017 6,863.0%   
Sales per share (Unadj.) Rs154.53.2 4,838.4%  
Earnings per share (Unadj.) Rs8.5-0.6 -1,304.7%  
Cash flow per share (Unadj.) Rs13.4-0.6 -2,079.8%  
Dividends per share (Unadj.) Rs10.000-  
Avg Dividend yield %1.60-  
Book value per share (Unadj.) Rs289.29.2 3,132.9%  
Shares outstanding (eoy) m24.695.98 412.9%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x4.12.7 154.1%   
Avg P/E ratio x75.1-13.1 -571.5%  
P/CF ratio (eoy) x47.5-13.2 -359.0%  
Price / Book Value ratio x2.20.9 238.0%  
Dividend payout %118.10-   
Avg Mkt Cap Rs m15,69151 30,784.8%   
No. of employees `000NANA-   
Total wages/salary Rs m1,0851 120,566.7%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3,81419 19,976.4%  
Other income Rs m3320 166,000.0%   
Total revenues Rs m4,14619 21,490.4%   
Gross profit Rs m267-1 -22,420.2%  
Depreciation Rs m1220 405,333.3%   
Interest Rs m773 2,713.8%   
Profit before tax Rs m400-4 -10,427.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1910 478,500.0%   
Profit after tax Rs m209-4 -5,386.6%  
Gross profit margin %7.0-6.2 -112.1%  
Effective tax rate %47.8-1.0 -4,830.5%   
Net profit margin %5.5-20.3 -27.0%  
BALANCE SHEET DATA
Current assets Rs m9,2242 397,564.7%   
Current liabilities Rs m3,5733 118,298.0%   
Net working cap to sales %148.2-3.6 -4,076.1%  
Current ratio x2.60.8 336.1%  
Inventory Days Days1761,611 10.9%  
Debtors Days Days370-  
Net fixed assets Rs m2,48084 2,937.8%   
Share capital Rs m12360 206.4%   
"Free" reserves Rs m7,018-5 -153,231.4%   
Net worth Rs m7,14155 12,935.0%   
Long term debt Rs m029 0.0%   
Total assets Rs m11,70387 13,493.9%  
Interest coverage x6.2-0.4 -1,741.0%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.30.2 148.0%   
Return on assets %2.4-1.2 -201.3%  
Return on equity %2.9-7.0 -41.6%  
Return on capital %6.7-1.2 -553.2%  
Exports to sales %9.30-   
Imports to sales %00-   
Exports (fob) Rs m354NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3540-   
Fx outflow Rs m9740-   
Net fx Rs m-6210-   
CASH FLOW
From Operations Rs m-692-1 53,651.2%  
From Investments Rs m952NA 1,359,428.6%  
From Financial Activity Rs m-3681 -35,728.2%  
Net Cashflow Rs m-1090 54,250.0%  

Share Holding

Indian Promoters % 0.0 73.3 -  
Foreign collaborators % 70.7 0.0 -  
Indian inst/Mut Fund % 0.9 0.0 -  
FIIs % 0.1 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 29.3 26.7 109.7%  
Shareholders   44,640 841 5,308.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   MMTC    HCL INFOSYS    SUNDRAM FASTENERS    FUTURE CONSUMER    STC INDIA    



Today's Market

Sensex, Nifty Recover from Day's Low to End Higher; Maruti Suzuki Hits New High Post Q3 Results(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views on News

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

5 Hidden Tata Group Companies to Add to Your Watchlist(Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Jan 25, 2022 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS - 7NR RETAIL COMPARISON

COMPARE NOVARTIS WITH

MARKET STATS